Other substances

Polymyxin E

A cyclic polypeptide antibiotic.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
2
 AI-suggested references
0
 Clinical trials

General information

Polymyxin E on PubChem

Synonyms

Colistin

Marketed as

ALFACOLIN; ALFICETIN; COLIFIN; COLIMICINA; COLY-MYCIN; COLIMYCINE; COLIRACIN; COLISTATE; COLOMYCIN CORTISPORIN; DIARÖNT MONO; PROMIXIN; TADIM; WALAMYCIN

 

Structure image - Polymyxin E

CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O

Supporting references

Link Tested on Impact factor Notes Publication date
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
Spike protein 3CLpro In silico 		in silico 4.07

Predicted to bind the SARS-CoV-2 spike protein.

 Sep/07/2020

AI-suggested references

Link Publication date
Use of topical colistin in bacterial keratitis caused by extensively drug-resistant Pseudomonas Aeruginosa: a case report.
Sep/23/2021
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
Oct/07/2020
Export (.csv)